Thymosin Alpha-1 (5mg)

CJC-1295 (No DAC) is a synthetic peptide fragment studied in laboratory and in-vitro research settings for its interaction with growth hormone–releasing hormone (GHRH) receptors. This compound is structurally designed without a Drug Affinity Complex (DAC), resulting in a shorter biological half-life compared to DAC-modified analogs.

In controlled research environments, CJC-1295 (No DAC) is commonly evaluated for its receptor-binding characteristics, signaling pathways, and degradation kinetics. Its rapid clearance profile makes it of interest for studies requiring precise temporal control during experimental observation.

This product is supplied strictly for laboratory research purposes only and is not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease.

SS-31 (5 mg) is a synthetic tetrapeptide developed for use in laboratory and analytical research environments, where it is studied for its affinity to mitochondrial membranes and its role in cellular bioenergetic pathways. In non-clinical research contexts, SS-31 is commonly evaluated to better understand mitochondrial structure-function relationships, oxidative stress markers, and peptide–membrane interactions under controlled experimental conditions.

This compound is provided as a lyophilized powder and is intended exclusively for use by qualified professionals trained in the handling of research chemicals. SS-31 is not intended for human or animal use and is not approved for diagnostic, therapeutic, or preventive applications. All handling, storage, and experimental use should follow established laboratory safety protocols and institutional guidelines.